Viewing Study NCT06792734


Ignite Creation Date: 2025-12-25 @ 2:24 AM
Ignite Modification Date: 2025-12-26 @ 5:48 PM
Study NCT ID: NCT06792734
Status: RECRUITING
Last Update Posted: 2025-09-18
First Post: 2025-01-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 1 Trial of BTM-3566 in Relapsed/Refractory Mature B Cell Lymphomas
Sponsor: Bantam Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module